KISQALI
NDC 0078-0860, ribociclib, tablet, film coated, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0860
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209092
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIBOCICLIB SUCCINATE200 mg/1
Pharmacologic classes
Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0860-01 | 00078086001 | 1 BLISTER PACK in 1 CARTON (0078-0860-01) / 21 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aaeaef94-f3f5-4367-8ea2-b181d7be2da8
Use it
Look up 0078-0860 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0860. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.